{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:00:11Z","timestamp":1775008811903,"version":"3.50.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:00:00Z","timestamp":1496707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBMR Plus"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:label\/><jats:p>Recombinant human parathyroid hormone (PTH) is the key anabolic agent used for preventing fracture in postmenopausal women with osteoporosis. In bone metabolism, PTH signaling is mediated through a G protein\u2013coupled receptor that affects various post\u2010receptor signaling pathways. Results of preclinical and clinical studies have shown that PTH improves both the structure and strength of bone tissue. Once daily subcutaneous injection of the PTH fragment, teriparatide (PTH [1\u201034]), is the most commonly recommended formulation and dosing strategy in clinical practice. However, other dosing intervals, formulations, and routes have been investigated in preclinical and clinical studies. In particular, once\u2010weekly and cyclical administration have been investigated mainly as a means of reducing the high direct costs of treatment. In preclinical studies, bone formation\/resorption markers, bone mineral density measurements, and histomorphometric parameters improved with both once\u2010daily and once\u2010weekly administration. However, the magnitude and duration of such improvements were generally greater with once\u2010daily PTH administration. In clinical studies, reductions in fracture incidence were also noted with both once\u2010daily and once\u2010weekly PTH administration, although improvements in nonvertebral fractures are less evident with once\u2010weekly administration. This narrative review details the differences between PTH formulation and dosing strategies in relation to preclinical and clinical efficacy\/safety parameters, although it should be stressed that no head\u2010to\u2010head studies allow direct comparisons. This review also seeks to outline practical considerations involved with PTH prescribing and new directions in research regarding routes of administration. \u00a9 2017 The Authors. <jats:italic>JBMR Plus<\/jats:italic> is published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jbm4.10005","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T12:05:35Z","timestamp":1491912335000},"page":"36-45","source":"Crossref","is-referenced-by-count":12,"title":["Influence of Dosing Interval and Administration on the Bone Metabolism, Skeletal Effects, and Clinical Efficacy of Parathyroid Hormone in Treating Osteoporosis: A Narrative Review"],"prefix":"10.1093","volume":"1","author":[{"given":"Kyoung Min","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism Department of Internal Medicine Seoul National University Bundang Hospital and Seoul National University College of Medicine Seongnam Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae Young","family":"Lee","sequence":"additional","affiliation":[{"name":"Lilly Korea Ltd. Jung\u2010ku Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Research Institute Severance Hospital, Yonsei University College of Medicine Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,6,6]]},"reference":[{"issue":"6","key":"e_1_2_9_2_1","first-page":"569","article-title":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7\u201029, 2000: highlights of the conference","volume":"94","year":"2001","journal-title":"South Med J"},{"issue":"6","key":"e_1_2_9_3_1","first-page":"785","article-title":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy","volume":"285","year":"2001","journal-title":"Osteoporosis prevention, diagnosis, and therapy. JAMA"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111096"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1258"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2009.04.001"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra067395"},{"key":"e_1_2_9_8_1","unstructured":"Forteo (teriparatide [rDNA origin] injection). Prescribing information. Indianapolis (IN): Lilly USA; 2016 [cited 2017 Apr 21]. Available from:http:\/\/www.forteo.com\/index."},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/ciia.2007.2.1.163"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-015-0050-1"},{"key":"e_1_2_9_11_1","unstructured":"Natpara (parathyroid hormone for injection). Prescribing information. Lexington (MA): Shire\u2010NPS Pharmaceuticals Inc. 2017 [cited 2017 Apr 21]. Available from:https:\/\/www.natpara.com\/."},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009464"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00040"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01428-09"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/941419"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031454"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.07.004"},{"issue":"4","key":"e_1_2_9_18_1","first-page":"499","article-title":"Teriparatide in the management of osteoporosis","volume":"2","author":"Bodenner D","year":"2007","journal-title":"Clin Interv Aging"},{"issue":"11","key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1\u201034) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig H","year":"1997","journal-title":"Endocrinology"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6610"},{"issue":"8","key":"e_1_2_9_21_1","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","article-title":"Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells","volume":"136","author":"Dobnig H","year":"1995","journal-title":"Endocrinology"},{"issue":"9","key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201038) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene\u2010associated bone formation","volume":"142","author":"Ma YL","year":"2001","journal-title":"Endocrinology"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.05.003"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00430-0"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040112"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.11.1932"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.051017"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050105"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050157"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1715"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-1703"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00005"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.1.9"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2781"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3479"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.879440"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1978"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-3001-1"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2838-7"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.07.091"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1379-y"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-013-9777-8"},{"issue":"6","key":"e_1_2_9_44_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt AM","year":"1987","journal-title":"J Bone Miner Res"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-015-9998-0"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1262"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04301206"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1573-6"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2822"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-004-0525-z"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-013-0505-2"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050151"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1004-0"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/01926230490462138"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1768"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1081\/ERC-200035957"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2011.05.007"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0159-1"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0358"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0171-5"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3581-z"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2015.11.001"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1376-1"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2014.13"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbm4.10005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jbm4.10005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:53:02Z","timestamp":1710424382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/1\/1\/36-45\/7478718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,6]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1002\/jbm4.10005"],"URL":"https:\/\/doi.org\/10.1002\/jbm4.10005","archive":["Portico"],"relation":{},"ISSN":["2473-4039","2473-4039"],"issn-type":[{"value":"2473-4039","type":"print"},{"value":"2473-4039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,6]]}}}